News

STAT37m
Belgian antitrust regulator fines three companies $12.8 million over pharmacy displays
The Belgian antitrust regulator sanctioned some of the largest purveyors of over-the-counter medicines, the latest effort by ...
BioSpace1h
Fact or Fiction? Unpacking FDA Commissioner Marty Makary’s First Interviews
As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...
Fierce Biotech1h
M&A remains ‘top priority’ for Big Pharmas in the face of tariff threat
Big Pharmas aren’t letting the looming threat of potential tariffs divert them from their M&A strategies for the year—at ...
GV Wire1h
US Pharma Tariffs Would Raise US Drug Costs by $51 Billion Annually, Report Finds
Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.
The Business Times1h
US pharma tariffs would raise US drug costs by US$51 billion annually, report finds
LONDON] A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, ...
ZAWYA1h
US pharma tariffs would raise US drug costs by $51bln annually, report finds
The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023 ...
Pharma tariffs could raise prescription drug costs by $51B - report
A report from industry trade group Pharmaceutical Research and Manufacturers of America (PhRMA), conducted by Ernst & Young, ...
KCUR1h
Trump's tariffs won't get him what he wants, Missouri supply chain expert says
Haitao Li, chair of the supply chain analytics department at the University of Missouri-St. Louis, says that the Trump ...
STAT2h
Pharmalittle: We’re reading about the FDA and revolving doors, a Novo win over compounders, and more
Scores of FDA employees are searching for an exit from an agency in turmoil, especially staffers tasked with reviewing drug ...
Exclusive: US pharma tariffs would raise US drug costs by $51 bln annually, report finds
A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S.
Trump's plans to assess tariffs on imported drugs could raise prices, cause drug shortages
Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...